DAFTAR PUSTAKA
1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36:67-74.
2. PERKENI (2011). Konsensus Pengelolaan dan pencegahan Diabetes Mellitus tipe 2 di Indonesia. Jakarta. PB PERKENI.
3. Herman JB, Goldbourt U. Uric acid and diabetes: observations in a population study. Lancet. 1982;2:240–3.
4. LV Qin, Meng XF, He FF, Chen S, Su H, Xiong J, et al. High seum uric acid and increased risk of type 2 diabetes: A systemic review and meta-analysis of prospective cohort studies. PLOS one. 2013;8(2):e56-64.
5. Kramer CK, Muhlen DV, Jassal SK, Connor EB. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: The Rancho Bernardo Study. Diabetes Care. 2009;32:1272-3.
6. Lee J, Sparrow D, Vokonas PS, Landsberg L & Weiss ST. Uric acid and coronary heart disease rik: Evidence of a role uric acid in the obesity-insulin resistance. Am J Epidemiol. 1995;142(3):288-94.
7. Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes and diabetes, A 15-years follow-up study. Am J Epidemiol. 2012;176(2):108-16.
8. Oda E, Kawai R, Sukumaran V, Watanabe K. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese man. Inter MedJ.2009;48:1785-91.
9. Ogbera AO & Azenabor AO. Hyperuricaemia and the metabolic syndrome in Type 2 DM. Diabetology & Metabolic Syndrome. 2010;2:24-8.
10. Causevic A, Semiz S, Dzankovic AM, Cico B, Dujic T, Malenica M, et al. Relevance of uric acid in progression of type 2 diabetes mellitus. Bosnian
Journal of Basic Medical Sciences.2010;10(1):54-9.
11. Nakagawa T, Cirillo P, Sato W, Gersch M, Sautin Y, RoncalC et al. The
conundrum of hyperuricemia, metabolicsyndrome, and renal disease. Intern
12. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between
resistanceto insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acidconcentration. J Am Med Assoc. 1991;266:3008–11.
13. Choi HK, De Vera MA & Krisnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology. 2008;47:1567-70. 14. Kaur A, Kukreja S, Malhotra N & Neha. Serum adenosine deaminase activity
and its correlation with glycated haemoglobin levels in patients of type 2 diabetes mellitus. Journal of Clinical and Diagnostic Research. 2012;6(2):252-6.
15. Gill A, Kukreja S, Malhotra N & Chhabra N. Correlation of the serum insulin and the serum uric acid levels with the glycated haemoglobin levels in the patients of type 2 diabetes mellitus. Journal of Clinical and Diagnostic
Research. 2013;7(7):1295-7.
16. Markkola HV & Jarvinen HY. Hyperuricemia and insulin resistance. J Clin
Endicrinol Metab.1994;78:25-29.
17. Meera KS, Vasudha KC & Sushmitha J. The study of serum uric acid levels in non dependent diabetes meliitus (NIDDM). Asian J Pharm Biol Res. 2011;1(3):260-6.
18. Choi HK, Ford ES. Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey. Rheumatology (Oxford).2008; 47:713–7. 19. Rodriguez LAG, Soriano LC, Bpharm & Choi HK. Impact of diabetes against
the future risk of developing gout. Ann Rheum Dis. 2010;69(12):2090-4.
20. Cook DG, Shaper AG, Thelle DS, Whitehead TP. Serum uric acid, serum glucose and diabetes:relationships in a population study. Postgrad Med J. 1986; 62:1001–6.
21. Safi AJ, Mehmood R, Khan MA & Haq AU. Association of serum uric acid with type 2 diabetes mellitus. Journal of Post Graduate Medical Institute. 2004;18(1):59-63.
23. Lehto S, Niskanen L, Ronnemaa T & Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus.
Stroke.1998;29:635-9.
24. Heinemann L & Richter B. Clinical Pharmacology of Human Insulin. Diabetes
Care. 1993;16(3):90-100.
25. Berry CE & JM Hare. Xanthine Oxidoreductase and Cardiovascular Disease: Molecular Mechanism and Pathophysiological Implications. Am
JPhysiol.2004;2:589-606.
26. Dincer HE, Dincer AP, Levinson DJ. Asymptomatic Hyperuricemia: ToTreat or Not To Treat. Cleveland Clinic Journal of Medicine. 2002;3:594-606.
27. Zhao Y, Yang X, Lu W, Liao H & Liao F. Uricase Based Methods for in Determination of Uric Acid in Serum.Microcim Acta. 2009;164:1-6.
28. Hediger MA, Johnson RJ, Miyazaki H & Endou H. Molecular Physiology of Urate Transport. Am J Physiol. 2005:12:125-33.
29. Heinig M and RJ Johnson. Role of Uric Acid in Hypertension, RenalDisease, and Metabolic Syndrome. Cleveland Clinic Journal of Medicine. 2006:11:1059-64.
30. Wang J, Chen RP, Lei L, Song QQ, Zhang RY, Li YB, et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China. Asia Pac J Clin Nutr. 2013;22(4):590-8.
31. Putra TR. Hiperurisemia. In: Sudoyo dkk (ed). Buku Ajar IlmuPeyakit Dalam
Jilid III Edisi V. Jakarta: FKUI, pp: 2550-5.
32. Cirillo P, Sato W, Reungjui S, Heinig M, Gersch M, Sautin Y, et al. Uric Acid, the metabolic syndrome and renal disease. J Am Soc Nephrol. 2006;17:165-8. 33. Cohen E, Krause I, Fraser A, Goldberg E & Garty M. Hyperuricemia and
metabolic syndrome: Lesson from a large cohort from Israel.
IMAJ.2012;14:676-80.
35. Johnson RJ, Kang DH, Feig DI, Kivlighn S, Kanelis J, Watanabe S, et al. Is There a Pathogenic Rule of Uric Acid in Hypertension, Cardiovascular and Renal Disease? Hypertension Journal. 2003:22(3):1183-90.
36. Stefan AD, Wolfram D, Mathias R, Rakesh S, Francis F, Christoph K, et al. Uric Acid and Survival in Chronic Heart Failure: Validation and Application in Metabolic, Functional, and Hemodynamic Staging. Circulation.2003;107:1991-7.
37. Zanardo RC, Cruz JW, Martinez LL, de Oliveira MA, Fortes ZB. Probucol restores the defective leukocyte-endothelial interaction in experimental diabetes.
Eur J Pharmacol. 2003;478:211–9.
38. Sannomiya P, Pereira MA, Garcia-Leme J. Inhibition of leukocyte chemotaxis by serum factor in diabetes mellitus: selective depression of cell responses mediated by complement-derived chemoattractants. Agents Actions. 1990; 30:369–76.
39. Niskanen L, Laaksonen DE, Lindstrom J, Eriksson JG, Keinanen-Kiukaanniemi S, Ilanne-Parikka P, et al. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabetes Care. 2006;29:709–11.
40. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32: 1737–42.
41. So A, Thorens B. Uric acid transport and disease. J Clin Invest.
42. DeFronzo RA, Cooke CR, Andres R, et al. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.
2010;120(6):1791–9.
J Clin Invest.
43. Ter Maaten JC, Voorburg A, Heine RJ, et al. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. 1975;55(4):845–55.
Clin
Sci (Lond).
45. Li-ying C, Wen-hua Z, Zhou-wen C, Hong-lei D, Jing-jing R, Jian-hua C, et al. Relationship between hyperuricemia and metabolic syndrome. Zhejiang Univ
Sci B. 2007;8(8):593-8.
46. Lia C, Hsiehb M C, Changc S J. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013;25:210–6.
47. Chen J H, Pan W H, Hsu C C, Yeh W T, Chuang S Y, Chen P Y, et al. Impact of Obesity and Hypertriglyceridemia on Gout Development With or Without
Hyperuricemia: A Prospective Study. Arthritis Care Res. 2013;65(1):133–40.
48. Carlioglu A, Karakurt F, Maral S, Kasapoglu B, Darcin T. Serum Uric Acid Levels in Obese Women. The New Journal of Medicine. 2011;28:34-7.
49. Kim S Y, Guevara J P, Kim K M, Choi H K, Heitjan D F, Albert D A. Hyperuricemia and Coronary Heart Disease: A Systematic Review and Meta-Analysis. Arthritis Care Res. 2010;62(2):170–80.
50. Ito H, Abe M, Mifune M, Oshikiri K, Antoku S, Takeuchi Y, et al. Hyperuricemia Is Independently Associated with Coronary Heart Disease and Renal Dysfunction in patients with Type 2 Diabetes MellitusTogane. Plos One. 2011;6(11):e27817-24.
51. Perticone F, Sciacqua A, Perticone M, Arturi P, Scarpino P E, Quero M, et al. Serum Uric Acid and 1-h Postload Glucose in Essential Hypertension. Diabetes
Care.2012;35:153–7.
52. Yılmaz M B, Erdem A, Yontar O C, Sarıkaya S, Yılmaz A, Madak N, et al. Relationship between HbA1c and coronary flow rate in patients with type 2 diabetes mellitus and angiographically normal coronary arteries.Arch Turk Soc
Cardiol. 2010;38(6):405-10.
53. Puddu P, Puddu G M, Cravero E, Vizioli L, Muscari A. The relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: Molecular mechanisms and clinical implications. J of Cardiol. 2012;59:235-42.